A Quantitative Systems Pharmacology Model of Glucose-Insulin Regulation to Guide the Design and Evaluation of Novel Basal Insulins with Optimal Risk-Benefit Profile
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要